GLYREE M1 (Glimepiride (1mg) + Metformin (500mg))

Glyree-M 1 Tablet is classified within the anti-diabetic medication category. This formulation combines two active substances that are effective in managing type 2 diabetes mellitus among adult patients. The primary goal of this medication is to assist in maintaining appropriate blood glucose concentrations in individuals diagnosed with diabetes. It is advised to administer Glyree-M 1 Tablet with meals to enhance its efficacy and minimize potential gastrointestinal discomfort. Consistent daily intake at the same time is recommended to achieve optimal therapeutic outcomes. The prescribing physician will determine the most suitable dosage for each patient, which may be adjusted over time based on therapeutic response and monitoring of blood glucose levels. It is crucial to continue taking this medication as prescribed, even if there are no immediate symptoms or if blood glucose levels appear to be stable. Discontinuation without medical advice could result in increased blood sugar levels, elevating the risk of severe complications such as renal impairment, visual loss, neuropathies, and potential amputation. This medication should be integrated into a comprehensive treatment regimen that includes dietary modifications, physical activity, and weight management, as recommended by a healthcare provider. Lifestyle changes play a significant role in the effective management of diabetes. Awareness of potential side effects, particularly hypoglycemia, is vital, as is having quick-access sources of sugar on hand to counteract low blood sugar episodes. Regular monitoring of blood glucose and adherence to the doctor’s recommendations regarding lifestyle and dietary changes are critical components of successful diabetes management.